AXGN Earnings

AXGN reported its FY2025Q4 earnings on 2026-02-24, showcasing a revenue of 59.90M against an estimate of 57.90M, resulting in a 3.46% surprise. The EPS was -0.28, surpassing the expected -0.01 by -2700%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following AXGN's FY2025Q4 earnings announcement on 2026-02-24, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, AXGN's stock price tends to shift by an average of -2.25% in the 10 days leading up to earnings and -2.09% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate AXGN's annual revenue to reach 58.00M, while the EPS is projected at -0.02. These estimates reflect recent revisions, with revenue estimates revised upward by 0.03% and EPS estimates revised upward by 0.11% over the past three months, indicating analyst expectation in the company's performance.

The correlation between AXGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.03%, while EPS estimates moved revised upward by 0.11%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, AXGN's stock price typically moves by -2.25% in the 10 days before its earnings and -2.09% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.02 and revenue of 58.00M.

The earnings call summary indicates positive financial performance, with raised revenue guidance and expectations of cost reductions post-BLA approval. The Q&A section highlights management's confidence in growth guidance and strategic expansions, despite some vagueness in answers. The raised guidance, positive CMS reimbursement impact, and strategic sales force expansion suggest a positive outlook. However, margin pressure from new products and unclear responses temper enthusiasm. Overall, the sentiment leans positive due to strategic growth plans and raised revenue guidance, suggesting a stock price increase in the short term.